Home Aquinox

Aquinox

acquired
IPO Delisting
Therapeutic Protein Drug Developer

Basic Information

At Aquinox Pharmaceuticals, they are committed to developing life-changing drugs.They believe there is an urgent need for a paradigm shift in the discovery of therapeutic proteins to overcome reliance on building blocks provided by nature.Their innovative computational platform enables the design of entirely new proteins from scratch to treat serious diseases, including cancer, inflammation, and autoimmune disorders.They are a team of physicians, scientists, and innovators whose visionary focus is on improving nature and enabling truly customized medical approaches.They are leading the protein design revolution.
Aquinox Pharmaceuticals Inc.
Vancouver,BritishColumbia,Canada
15~50 people
January 01, 2004
info@aqxpharma.com